Genexine, Inc.
Clinical-stage biotech developing long-acting therapeutics for oncology and rare diseases.
095700 | KO
Overview
Corporate Details
- ISIN(s):
- KR7095700001
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 강서구 마곡중앙로 172 바이오이노베이션파크, 강서구
- Website:
- http://www.genexine.com/
- Sector:
- Manufacturing
Description
Genexine, Inc. is a clinical-stage biotechnology company focused on developing and commercializing immunotherapeutics and next-generation biologics. The company utilizes its proprietary hyFc® platform technology to create long-acting protein therapeutics. Its pipeline is led by GX-I7, a long-acting interleukin-7 designed to amplify T-cell counts for immuno-oncology applications. Other key assets in late-stage clinical trials include GX-E4, a long-acting treatment for anemia, and GX-H9 for growth hormone deficiency. Genexine's research and development efforts primarily target oncology and rare diseases.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-03-28 00:00 |
정기주주총회결과
|
Korean | 24.5 KB | ||
| 2024-03-20 00:00 |
투자판단관련주요경영사항(임상시험계획승인신청) (건강한 자원자 코카시안 및 아시아인에서 efepoetin alfa 단회 …
|
Korean | 9.2 KB | ||
| 2024-03-13 00:00 |
사업보고서 (2023.12)
|
Korean | 542.2 KB | ||
| 2024-03-13 00:00 |
주주총회소집결의
|
Korean | 11.9 KB | ||
| 2024-03-13 00:00 |
주주총회소집공고
|
Korean | 193.0 KB | ||
| 2024-03-13 00:00 |
의결권대리행사권유참고서류
|
Korean | 176.3 KB | ||
| 2024-03-13 00:00 |
주식매수선택권부여에관한신고
|
Korean | 14.6 KB | ||
| 2024-03-12 00:00 |
감사보고서제출
|
Korean | 25.7 KB | ||
| 2024-02-07 00:00 |
매출액또는손익구조30%(대규모법인은15%)이상변동
|
Korean | 11.0 KB | ||
| 2024-01-31 00:00 |
[기재정정]투자판단관련주요경영사항(GX-E4(지속형 빈혈 치료제)기술이전 계약체결)
|
Korean | 17.6 KB | ||
| 2024-01-26 00:00 |
[기재정정]투자판단관련주요경영사항(에페사프리필드시린지주(GX-E4) 한국 품목허가 신청)
|
Korean | 15.0 KB | ||
| 2024-01-25 00:00 |
투자판단관련주요경영사항(에페사프리필드시린지주(GX-E4) 한국 품목허가 신청)
|
Korean | 11.3 KB | ||
| 2024-01-09 00:00 |
[기재정정]감사보고서제출(2021사업연도)
|
Korean | 35.4 KB | ||
| 2024-01-09 00:00 |
[기재정정]감사보고서제출(2022사업연도)
|
Korean | 41.1 KB | ||
| 2024-01-09 00:00 |
[기재정정]사업보고서 (2021.12)
|
Korean | 1.9 MB |
Automate Your Workflow. Get a real-time feed of all Genexine, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Genexine, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Genexine, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
